Recently, a review paper titled “The Molecular Mechanisms of Cardiac Development and Related Diseases” was published in Signal Transduction and Targeted Therapy, a sub-journal of Nature, by Professor SHE Qiang’s team from the Second Affiliated Hospital of CQMU.
The paper provides a comprehensive overview of various congenital heart defects and current therapeutic strategies for congenital heart diseases. It offers insights into future therapeutic approaches, including the potential of innovative treatments such as cell therapy, fetal cardiac intervention, and targeted drugs. Additionally, the review explores the application of clinical gene testing and artificial intelligence in early diagnosis, risk prediction, and personalized treatment. Furthermore, it discusses integrating multi-omics data and AI technology to explore risk factors for congenital heart diseases and the future directions of early prevention strategies. This research aims to better understand molecular mechanisms in cardiac development and provide more substantial support for the early prevention and treatment of congenital heart diseases in the future.
Full Article Link: //www.pk8528.com/info/1063/2293.htm
